SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 396,012 shares at $25.51 ($10.1M) on 2023-05-03, disclosed to the SEC on 2023-05-05.
Open-market sale of $10.1M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.51 | 83,674 | $2.1M | 21.1% |
| 2 | $25.51 | 83,674 | $2.1M | 21.1% |
| 3 | $25.55 | 114,332 | $2.9M | 28.9% |
| 4 | $25.55 | 114,332 | $2.9M | 28.9% |
| Total | $25.53 avg | 396,012 | $10.1M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |